Morgan Stanley’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.7M | Sell |
445,880
-79,816
| -15% | -$2.27M | ﹤0.01% | 3223 |
|
|
2025
Q1 | $15.5M | Sell |
525,696
-688,080
| -57% | -$20.3M | ﹤0.01% | 2944 |
|
|
2024
Q4 | $35.3M | Buy |
1,213,776
+602,539
| +99% | +$17.5M | ﹤0.01% | 2166 |
|
|
2024
Q3 | $28.1M | Sell |
611,237
-642,997
| -51% | -$29.5M | ﹤0.01% | 2447 |
|
|
2024
Q2 | $51.2M | Sell |
1,254,234
-283,062
| -18% | -$11.6M | ﹤0.01% | 1734 |
|
|
2024
Q1 | $39.2M | Sell |
1,537,296
-1,444,190
| -48% | -$36.9M | ﹤0.01% | 1982 |
|
|
2023
Q4 | $27M | Buy |
2,981,486
+1,823,904
| +158% | +$16.5M | ﹤0.01% | 3082 |
|
|
2023
Q3 | $7.39M | Buy |
1,157,582
+58,987
| +5% | +$376K | ﹤0.01% | 3399 |
|
|
2023
Q2 | $12.2M | Sell |
1,098,595
-153,867
| -12% | -$1.71M | ﹤0.01% | 2977 |
|
|
2023
Q1 | $19.2M | Buy |
1,252,462
+227,610
| +22% | +$3.49M | ﹤0.01% | 2477 |
|
|
2022
Q4 | $22.7M | Buy |
1,024,852
+944,272
| +1,172% | +$21M | ﹤0.01% | 2207 |
|
|
2022
Q3 | $1.32M | Sell |
80,580
-53,649
| -40% | -$876K | ﹤0.01% | 4718 |
|
|
2022
Q2 | $1.95M | Buy |
134,229
+24,857
| +23% | +$361K | ﹤0.01% | 4561 |
|
|
2022
Q1 | $2.02M | Buy |
109,372
+34,555
| +46% | +$639K | ﹤0.01% | 4522 |
|
|
2021
Q4 | $1.78M | Sell |
74,817
-48,020
| -39% | -$1.14M | ﹤0.01% | 4672 |
|
|
2021
Q3 | $3.03M | Buy |
122,837
+20,654
| +20% | +$509K | ﹤0.01% | 4219 |
|
|
2021
Q2 | $2.53M | Sell |
102,183
-54,357
| -35% | -$1.34M | ﹤0.01% | 4457 |
|
|
2021
Q1 | $3.41M | Buy |
156,540
+89,317
| +133% | +$1.95M | ﹤0.01% | 3805 |
|
|
2020
Q4 | $1.72M | Buy |
67,223
+62,178
| +1,232% | +$1.59M | ﹤0.01% | 4282 |
|
|
2020
Q3 | $142K | Buy |
+5,045
| New | +$142K | ﹤0.01% | 5268 |
|